1.Immediate effect of cigarette smoking on exercise.
Kang Hyeon CHOE ; Cheol Jun CHOI ; Yong Tae KIM ; Chae Man LIM ; Younsuck KOH ; Woo Sung KIM ; Won Dong KIM
Tuberculosis and Respiratory Diseases 1992;39(6):511-516
No abstract available.
Smoking*
;
Tobacco Products*
2.A Case of Severe Pneumonia with Rhabdomyolysis Caused by Mycoplasma Pneumonia.
Gwang Beom KOH ; Ki Ho PARK ; Sang Ho CHOI ; Gwang Hyeon CHOI ; Ji Hoon KANG ; Jong Sik KANG ; Youn Suck KOH
Korean Journal of Medicine 2012;83(3):390-394
Mycoplasma pneumoniae is a common cause of respiratory tract infections and typically causes mild disease. Extrapulmonary manifestations of M. pneumoniae infection are also common, but rhabdomyolysis is a rare complication. Here, we describe the case of a previously healthy 23-year-old male who displayed the simultaneous onset of rhabdomyolysis and severe pneumonia requiring mechanical ventilation. Both conditions were resolved by a 10-day course of antimicrobial treatment and the patient was discharged without complication.
Humans
;
Male
;
Mycoplasma
;
Mycoplasma pneumoniae
;
Pneumonia
;
Pneumonia, Mycoplasma
;
Respiration, Artificial
;
Respiratory Tract Infections
;
Rhabdomyolysis
;
Young Adult
3.The Comparison of Work of Breathing Between Before Extubation and After Extubation of Endotracheal Tube.
Bock Hyun JUNG ; Youngsuck KOH ; Chae Man LIM ; Kang Hyeon CHOE ; Sang Do LEE ; Woo Sung KIM ; Dong Soon KIM ; Won Dong KIM
Tuberculosis and Respiratory Diseases 1997;44(2):329-337
BACKGROUND: Since endotracheal tube is the most important factor involved in the imposed work of breathing during mechanical ventilation, extubation of endotracheal tube is supposed to reduce respiratory work of patient. However, some patients show labored breathing after extubation despite acceptable blood gases. We investigated the changes of work of breathing before and after extubation and the factors involved in the change of WOB after extubation. METHODS: The subjects were 34 patients(M : F = 20 : 14, mean age = 61 l7yre) who recovered from respiratory failure after ventilatory support and were considered to be ready for extubation. The patients with clinical or radiologic evidences of upper airway obstruction before endotracheal intubation for mechanical ventilation were excluded. Vital sign, physical examination, chest X-ray, work of breathing and other respiratory mechanic indices were measured prior to, immediately, 6, 24 and 48 hours after extubation serially. Definition of weaning failure after extubation was resumption of ventilatory support or reintubation of endotracheal tube within 48 hour after extubation because of respiratory failure. The patients were classified into group I (decreased work of breathing), group 2(unchanged work of breathing) and group 3(increased work of breathing) depending on the statistical difference in the change of work of breathing before and after extubation. RESULTS: Work of breathing decreased in 33%(11/34, group 1), unchanged in 41%(14/34, group 2) and increased in 26% (9/34, group 3) of patients after extubation compared with before extubation. Weaning failure occurred 9%(1/11) of group, 1, 28.67(4/14) of group 2 and 44.4%(4/9) of group 3 after extubation(p = 0.07). The change of work of breathing after extubation was positively correlated with change of mean airway resistance(mRaw). (r = 0.794, p> 0.01) In three cases of group 3 whose respiratory indices could be measured until 48 hr ater extubation, the change in work of breathing paralleled with the sequential change of mRaw. The work of breathing was peaked at 6 hr after extubation, which showed a tendency to decrease thereafter. CONCLUSIONS: Reversible increase of work of breathing after extubation may occur in the patients who underwent extubation, and the increase in mRaw could be responsible for the increase in work of breathing. In addition, the risk of weaning failure after extubatuion may increase in the patients who have increased WOB immediately after extubation.
Airway Obstruction
;
Gases
;
Humans
;
Intubation, Intratracheal
;
Physical Examination
;
Respiration
;
Respiration, Artificial
;
Respiratory Insufficiency
;
Respiratory Mechanics
;
Thorax
;
Vital Signs
;
Weaning
;
Work of Breathing*
4.A Case of Human Rabies Confirmed by Polymerase Chain Reaction.
Sang Hyeon LEE ; Im Seok KOH ; Heue Kyung KWON ; Jung Woo KANG ; Phil Za CHO
Journal of the Korean Neurological Association 2002;20(4):437-438
The human rabies is a fatal infectious disease invading the central nervous system. There are many cases of clinically suspicious human rabies encephalitis in Korea since 1906. A 53-year old man was admitted to the Department of Neurology because of rapidly progressive dysphagia. His sputum was examined and the rabies virus was found by the polymerase chain reaction technique. So we report a case of human rabies encephalitis confirmed by detection of the rabies virus from his saliva.
Central Nervous System
;
Communicable Diseases
;
Deglutition Disorders
;
Encephalitis
;
Humans*
;
Korea
;
Middle Aged
;
Neurology
;
Polymerase Chain Reaction*
;
Rabies virus
;
Rabies*
;
Saliva
;
Sputum
5.The predictive value of serum myeloma protein in solitary plasmacytoma
Won Ick CHANG ; Hyeon Kang KOH ; Sung-Soo YOON ; Han-Soo KIM ; Keun-Yong EOM ; Il Han KIM
Radiation Oncology Journal 2020;38(2):129-137
Purpose:
To identify the clinical usefulness of serum M protein and to establish a rationale for regular follow-up with serum protein electrophoresis in solitary plasmacytoma.
Materials and Methods:
Sixty-nine patients with solitary plasmacytoma and solitary plasmacytoma with minimal marrow involvement according to the International Myeloma Working Group criteria were retrospectively reviewed.
Results:
At a median follow-up of 6.2 years, 5-year local control (LC), 5-year multiple myeloma-free survival (MMFS), 5-year failure-free survival (FFS), and 5-year overall survival (OS) were 82.6%, 44.1%, 41.8%, and 85.1%, respectively. Among the patients whose initial serum M protein was present or not evaluated, 37.3% of patients showed disappearance of serum M protein after various treatment. MMFS of these patients were comparable to non-secretory plasmacytoma with undetectable levels of M protein, and significantly better than patients with persistent M protein. Increase of serum M protein ≥0.1 g/dL was most predictive of treatment failure with area under the curve of 0.731.
Conclusion
Patients who eventually showed persistence of serum M protein after treatment showed worse MMFS and FFS compared to those whose serum M protein disappeared or who had initially non-secretory disease. The increase of serum M protein level ≥0.1 g/dL from current nadir was predictive of treatment failure. Therefore, regular follow-up with serum M protein is highly recommended especially unless the patient had initially non-secretory disease.
6.Pain Management Based on NCCN Guideline in Patients with Lung Cancer.
Hyeon Tae KIM ; Kyung Won KOH ; Yeo Myeong KIM ; Min Soo KANG ; Hee Sun NOH ; Hye Ryoun KIM ; Cheol Hyeon KIM ; Jae Cheol LEE
Tuberculosis and Respiratory Diseases 2009;67(3):221-225
BACKGROUND: Pain is one of the most troublesome problems caused by malignancy. We evaluated the change in pain status according to observance of NCCN guidelines in lung cancer patients. METHODS: Lung cancer patients complaining of pain at admission were examined. The pain was assessed with visual analogue scale (VAS) for 20 days and moderate-to-severe pain was defined as more than VAS level 3. The guideline observance was classified as high (more than 80%), medium (50~79%) and low (less than 50%). RESULTS: Among the total 91 lung cancer patients with pain, 34 patients (37%) had moderate-to-severe pain. Their average VAS score at admission was 5.6. It decreased to 2.9 after a 20-day period of pain management. The time to reach a VAS less than 3 was 3 days in a high guideline observance group, while it took 6 days in a low observance group. In addition, the pain in the high observance group was controlled to less than 3 VAS level in 86% of patients, whereas only 25% of patients in the low observance group succeeded. CONCLUSION: Pain was more effectively controlled when the dose of drugs was modified according to NCCN guidelines in lung cancer patients indicating the importance of guideline observance in pain management.
Humans
;
Lung
;
Lung Neoplasms
;
Pain Management
7.Proton Beam Radiotherapy for Pediatric Gliomas: Early Outcomes and Dose Comparison
Hyeon Kang KOH ; Byung Jun MIN ; Jeong Hoon PARK ; Kwan Ho CHO ; Hyeon Jin PARK ; Sang Hoon SHIN ; Joo Young KIM
Clinical Pediatric Hematology-Oncology 2013;20(1):40-50
BACKGROUND: Proton beam radiotherapy (PBT) has shown to provide high radiation dose to tumors and to save surrounding normal tissues because of its physical characteristics, Bragg peak. In the current study, we report the early outcomes for pediatric patients with intracranial gliomas treated with PBT and compared PBT plan (pencil beam scanning and double scattering) with intensity modulated radiotherapy (IMRT) plan and three dimensional-conformal radiotherapy (3D-CRT) plan.METHODS: Clinical data from 18 consecutive children with intracranial gliomas who underwent PBT from May 2007 to April 2012 was collected. The median follow-up duration was 16 months (range 6-69).RESULTS: There were 9 patients with brain stem glioma, 2 patients with optic pathway glioma, 2 patients with low grade glioma (LGG), 2 patients with anaplastic astrocytoma (AA) and 3 patients with glioblastoma multiforme (GBM). The median overall survival for patients with brain stem glioma was 11 months. Patients with optic pathway glioma, LGG or AA were all alive without progression except one patient. Among patients with GBM, one patient had no evidence of disease 25 months after PBT. When PBT plan was compared to those of IMRT and 3D-CRT for patients with LGG or AA and one patient with brain stem glioma by DVH analysis, PBT showed better sparing effect on normal tissue compared to IMRT and 3D-CRT, especially in low dose area.CONCLUSION: PBT could be delivered safely and effectively to pediatric patients with gliomas. For confirming the clinical benefits of PBT, further follow-up is necessary.
Astrocytoma
;
Brain Stem
;
Child
;
Follow-Up Studies
;
Glioblastoma
;
Glioma
;
Humans
;
Organ Sparing Treatments
;
Pediatrics
;
Proton Therapy
;
Protons
8.Salvage radiotherapy for lymph node recurrence after radical surgery in cervical cancer.
Wan JEON ; Hyeon Kang KOH ; Hak Jae KIM ; Hong Gyun WU ; Jin Ho KIM ; Hyun Hoon CHUNG
Journal of Gynecologic Oncology 2012;23(3):168-174
OBJECTIVE: This study was to evaluate the treatment outcomes and prognostic factors of patients treated with salvage radiotherapy for the treatment of isolated lymph node recurrence of cervical cancer. METHODS: Between 1990 and 2009, 22 cervical cancer patients with lymph node recurrence who had previously undergone radical hysterectomy and pelvic lymph node dissection were treated with salvage radiotherapy with (n=18) or without (n=4) chemotherapy. Of the 22 patients, 10 had supraclavicular lymph node recurrence, 9 had para-aortic lymph node, and 3 had inguinal lymph node. The median total radiotherapy dose was 60 Gy (range, 40 to 70 Gy). Initial pathologic findings, latent period to lymph node recurrence and other clinical parameters such as squamous cell carcinoma antigen (SCC-Ag) level and concurrent chemotherapy were identified as prognostic factors for survival. RESULTS: The median follow-up period after salvage radiotherapy was 31.2 months (range, 12.1 to 148.9 months). The 5-year progression-free and overall survival rates of all patients were 32.7% and 30.7%, respectively. Concurrent chemoradiotherapy (p=0.009) and longer latent period to lymph node recurrence (>18 months vs. < or =18 months, p=0.019) were significant predictors of progression-free survival and SCC-Ag level at the time of recurrence (>8 ng/dL vs. < or =8 ng/dL, p=0.008) and longer latent period to lymph node recurrence (p=0.040) for overall survival. Treatment failure after salvage radiotherapy occurred in 14 (63.6%) for the 22 patients (in field, 2; out of field, 10; both in and out field, 2). Grade 3 acute skin (n=2) and hematologic toxicity (n=1) developed in 3 patients. CONCLUSION: For isolated lymph node recurrence of cervical cancer, salvage radiotherapy with concurrent chemotherapy should be considered, especially in patients with a long-term progression-free period.
Antigens, Neoplasm
;
Carcinoma, Squamous Cell
;
Chemoradiotherapy
;
Disease-Free Survival
;
Follow-Up Studies
;
Humans
;
Hysterectomy
;
Lymph Node Excision
;
Lymph Nodes
;
Recurrence
;
Salvage Therapy
;
Serpins
;
Skin
;
Survival Rate
;
Treatment Failure
;
Uterine Cervical Neoplasms
9.Two Different Causes of Intestinal Obstruction in Lung Cancer.
Min Sung HAN ; Kyung Won KOH ; Yeo Myung KIM ; Min Soo KANG ; Du Hwan CHOE ; Hye Ryoun KIM ; Cheol Hyeon KIM ; Jae Cheol LEE
Tuberculosis and Respiratory Diseases 2009;66(5):365-369
No abstract available.
Intestinal Obstruction
;
Lung
;
Lung Neoplasms
;
Superior Mesenteric Artery Syndrome
10.The Effect of Intra-Arterial Low-Dose Nicardipine for the Treatment of Aneurysmal Subarachnoid Hemorrhage-associated Vasospasm.
Jae Kyung SUNG ; Chang Woo KANG ; Hyon Jo KWON ; Hyeon Song KOH ; Seung Won CHOI ; Shi Hun SONG
Korean Journal of Cerebrovascular Surgery 2011;13(3):184-193
OBJECTIVE: Delayed cerebral ischemia due to vasospasm after aneurysmal subarachnoid hemorrhage (SAH) is a leading cause of morbidity and mortality. Recent reports have confirmed that intra-arterial infusion of calcium-channel blockers, which are widely used to counteract vasospasm, is effective for treating SAH with a low risk of complications. Here we report on our experience with intra-arterial nicardipine angioplasty in a consecutive series of 32 patients with SAH. METHODS: This retrospective review evaluated a series of 32 consecutive patients with symptomatic vasospasm that was treated with intra-arterial nicardipine. The patients included in the study were diagnosed with aneurysmal SAH between January 2007 and February 2011. All the patients underwent microsurgical clipping or endovascular coiling. Angioplasty using intra-arterial nicardipine was performed in those patients who were refractory to medical therapy such as triple H therapy. RESULTS: The 32 patients underwent a total of 55 procedures. The total amount of nicardipine used in each angioplasty procedure did not exceed 12 mg, with a maximum dose of 3 mg for each vessel. The Glasgow Coma Scale (GCS) score improved in all patients with an average improvement of 2.4 (range : 1~5). During angioplasty, there were no complications such as thromboembolic events and/or acute transitory spasm. The clinical results were evaluated using the modified Rankin Scale (mRS). Good outcomes (mRS 0~2) were determined in 19 (63.3%) of the 30 patients. The 11 patients (36.7%) with poor outcomes initially had a high Hunt and Hess grade (III or IV) or they had intra-operative complications (mRS: 3~6). CONCLUSION: Our study results support the effectiveness and safety of low-dose nicardipine when performing intra-arterial angioplasty for the treatment of vasospasm after aneurysmal SAH.
Aneurysm
;
Angioplasty
;
Brain Ischemia
;
Glasgow Coma Scale
;
Glycosaminoglycans
;
Humans
;
Infusions, Intra-Arterial
;
Nicardipine
;
Retrospective Studies
;
Spasm
;
Subarachnoid Hemorrhage